The efficacy of inhaled antibiotics to treat chronic Pseudomonas aeruginosa pulmonary infection in patients with cystic fibrosis (CF) has been well established. Few data are available on the value of continuous alternating inhaled antibiotic therapy (CAIT), a strategy increasingly used in the management of CF.status: publishe
Bronchiectasis is a pathological diagnosis describing dilatation of the airways and is characterized...
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of pa...
BACKGROUND Shortcomings of inhaled antibiotic treatments for Pseudomonas aeruginosa infection in ...
The efficacy of inhaled antibiotics to treat chronic Pseudomonas aeruginosa pulmonary infection in p...
SummaryCommercial availability of more than one inhaled antibiotic for the management of chronic Pse...
Background/Aims: In cystic fibrosis (CF), chronic microbial lung infections are difficult to treat...
SummaryThe use of inhaled therapies for chronic respiratory infections in cystic fibrosis represents...
The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas a...
SummaryChronic airway infection and inflammation are key events in the clinical course of cystic fib...
AbstractBackgroundVarious inhaled antibiotics are currently used for treating chronic Pseudomonas ae...
The administration of antibiotics by the inhaled route offers an appealing and logical approach to t...
Chronic infection of the respiratory tract is a hallmark of cystic fibrosis (CF). Antibiotic treatme...
Abstract Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients is caused by...
Respiratory infection in cystic fibrosis develops in the first years of life and plays a key role in...
Introduction: CF pulmonary guidelines recommend alternate therapy (one month on, one month off) with...
Bronchiectasis is a pathological diagnosis describing dilatation of the airways and is characterized...
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of pa...
BACKGROUND Shortcomings of inhaled antibiotic treatments for Pseudomonas aeruginosa infection in ...
The efficacy of inhaled antibiotics to treat chronic Pseudomonas aeruginosa pulmonary infection in p...
SummaryCommercial availability of more than one inhaled antibiotic for the management of chronic Pse...
Background/Aims: In cystic fibrosis (CF), chronic microbial lung infections are difficult to treat...
SummaryThe use of inhaled therapies for chronic respiratory infections in cystic fibrosis represents...
The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas a...
SummaryChronic airway infection and inflammation are key events in the clinical course of cystic fib...
AbstractBackgroundVarious inhaled antibiotics are currently used for treating chronic Pseudomonas ae...
The administration of antibiotics by the inhaled route offers an appealing and logical approach to t...
Chronic infection of the respiratory tract is a hallmark of cystic fibrosis (CF). Antibiotic treatme...
Abstract Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients is caused by...
Respiratory infection in cystic fibrosis develops in the first years of life and plays a key role in...
Introduction: CF pulmonary guidelines recommend alternate therapy (one month on, one month off) with...
Bronchiectasis is a pathological diagnosis describing dilatation of the airways and is characterized...
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of pa...
BACKGROUND Shortcomings of inhaled antibiotic treatments for Pseudomonas aeruginosa infection in ...